Loading clinical trials...
Loading clinical trials...
A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical FibrocapsTM (RaplixaTM) and Tachosil® in Surgical Hemostasis During Hepatic Resection
Conditions
Interventions
Fibrocaps
TachoSil
Locations
15
Austria
Universitaetsklinik Innsbruck
Innsbruck, Austria
Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.
Linz, Austria
Medizinische Universitaet Wien AKH
Vienna, Austria
Universitaetsklinikum Aachen, RWTH
Aachen, Germany
Charite Campus Virchow-Klinikum
Berlin, Germany
Krankenhaus Nordwest GmbH
Frankfurt am Main, Germany
Start Date
November 1, 2014
Primary Completion Date
August 1, 2015
Completion Date
August 1, 2015
Last Updated
August 16, 2017
NCT02117349
NCT01653769
NCT01731938
NCT01754480
NCT02159105
Lead Sponsor
Mallinckrodt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions